ArticleJournal of cellular and molecular medicine2021

Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1α-C/EBPα-HNF4α axis.

Mingjie Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.